1. Home
  2. SOTK vs XLO Comparison

SOTK vs XLO Comparison

Compare SOTK & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sono-Tek Corporation

SOTK

Sono-Tek Corporation

N/A

Current Price

$4.25

Market Cap

71.0M

Sector

Technology

ML Signal

N/A

XLO

Xilio Therapeutics Inc.

N/A

Current Price

$8.20

Market Cap

56.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SOTK
XLO
Founded
1975
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.0M
56.9M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
SOTK
XLO
Price
$4.25
$8.20
Analyst Decision
Strong Buy
Buy
Analyst Count
2
2
Target Price
$8.50
★ $18.00
AVG Volume (30 Days)
★ 105.0K
13.3K
Earning Date
10-14-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 37.50
N/A
EPS
★ 0.07
N/A
Revenue
$20,909,315.00
★ $43,766,000.00
Revenue This Year
$2.67
$3.55
Revenue Next Year
$23.22
$9.26
P/E Ratio
$62.14
★ N/A
Revenue Growth
1.97
★ 589.88
52 Week Low
$3.40
$0.46
52 Week High
$7.48
$22.60

Technical Indicators

Market Signals
Indicator
SOTK
XLO
Relative Strength Index (RSI) 32.35 41.60
Support Level $4.25 $7.29
Resistance Level $4.62 $9.21
Average True Range (ATR) 0.28 0.58
MACD -0.06 0.02
Stochastic Oscillator 11.03 45.89

Price Performance

Historical Comparison
SOTK
XLO

About SOTK Sono-Tek Corporation

Sono-Tek Corp designs and manufactures ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial, and emerging research & development/other markets. The company designs and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with applications engineering knowledge, to assist its customers in achieving their desired coating solutions.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

Share on Social Networks: